NMN zwitterion/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases pittsburgh Sleep Quality Index global score
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“The NMN group had improved sleep quality at 12 weeks relative to the placebo group as evidenced by lower scores for "Daytime dysfunction" and "Global PSQI" on the Pittsburgh Sleep Questionnaire.”
Quoted verbatim from Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.. - Study
- RCT
- Duration
- 3 months
- Dose
- 250 mg/day NMN for 12 weeks
- Population
- Older adults in a randomized, placebo-controlled, double-blind, parallel-group trial; NMN group versus placebo group at 12 weeks
Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.2024PMID:38789831Permalink
Keep reading
- Everything the graph holds on NMN zwitterion
- Every compound studied against Pittsburgh Sleep Quality Index global score
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PNGH6XJBB53XVTJ6E6MHBM